Johan Flygare, Coordinator of the Swedish National ATMP Research School, explains more about the school and why you should apply in this interview from last year, made by Intramed.
Call for applications to the Swedish National ATMP Research School for 2025/26
Deadline is January 20, 2025.
What is ATMP?
ATMP (Advanced Therapy Medicinal Products ) is a term used by the European Medicines Agency (EMA) for medicines that are based on genes, tissues or cells. ATMPs represent a new frontier in the field of medicine that offer groundbreaking new therapeutic opportunities for diseases and injuries that are currently difficult or impossible to cure.
A few ATMPs are already in the clinic, and in a few years a large part of drug sales will be ATMPs. I think it is similar to when the first recombinant protein drugs reached patients in the 1980s, it was a small revolution.
This however comes with a big challenge, there are too few laboratory and health care professionals in Sweden trained to develop and administer these new drugs.
Call for applications
The open call for applications to join the National ATMP Research School for the 2025/2026 academic year is open until 20 January, 2025.
The school offers three different types of students the opportunity to join our program: co-funded PhD students, affiliated PhD students, and students interested in taking stand-alone courses. Here you can find more information about how to apply to the National ATMP Research School.